Company Performance: Positive earnings reports, strong revenue growth, successful drug development milestones, and positive clinical trial results typically drive the stock price up. Conversely, negative news has the opposite effect. Industry Trends: Developments in the broader pharmaceutical and biotechnology industries, such as regulatory changes, competitor activities, and technological advancements, can impact investor sentiment towards ONK.F. Market Conditions: General economic conditions, overall market volatility, and investor risk appetite can influence the stock price. Bull markets tend to lift most stocks, while bear markets depress them. Regulatory Approvals: The success or failure of ONK.F in obtaining regulatory approvals for its drug candidates from agencies like the FDA is a major price driver. Approval leads to commercialization and revenue potential. Competition: The presence and success of competing therapies from other companies can affect the market share and profitability of ONK.F's drugs, thereby influencing its stock price. Financial Health: The company's financial stability, including its cash reserves, debt levels, and ability to raise capital, is a key determinant of investor confidence and stock valuation.